Scilex Divests Vivasor Preferred Stock for $12M

Scilex Holding Company has entered into a stock repurchase agreement with Vivasor Holding Company to sell its previously acquired preferred shares of Vivasor. The transaction involves the sale of 6,101,468 Series A-1 and 355,919 Series A-2 preferred shares for an aggregate purchase price of $11,999,762.28. The payment will be made in five tranches, with the final payment scheduled by June 30, 2027, and can include wire transfers or assignment of Datavault AI, Inc. common stock. Notably, Scilex's CEO, Dr. Henry Ji, also holds the CEO position at Vivasor.